Law360, New York (February 18, 2010, 3:44 PM EST) -- GlaxoSmithKline PLC has decided to voluntarily pull its zinc-containing lines of Poligrip denture cream from the market and stop all advertising and manufacture of the creams, as suits pile up in the multidistrict litigation over neurological problems from excessive zinc levels caused by denture products.
GSK has taken voluntary, precautionary action to end the manufacture and supply of its zinc-containing denture adhesives marketed across many countries, the company said Thursday.
GSK said it would transition to zinc-free versions of all its affected product variants, and the...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.